Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Indivior ( (GB:INDV) ) has provided an announcement.
Indivior PLC announced that Robert Schriesheim, a Non-Executive Director, acquired 21,400 Ordinary Shares at $11.73 each on December 20, 2024. This transaction reflects a potential vote of confidence in the company’s operations and market positioning, potentially signaling positive implications for stakeholders.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing primarily on the development and distribution of medications for addiction treatment and related health issues.
YTD Price Performance: -22.83%
Average Trading Volume: 462,023
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.15B
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.
